One proof‐of‐concept study demonstrated that a single‐dose oral FMT from healthy lean donors combined with a daily low‐fermentable fiber supplementation produced small but statistically significant improvements in insulin sensitivity in patients with severe obesity and metabolic syndrome [105]. The gene discussed is INS; the disease is Obesity.